# New Medication Treatment for Stimulant Dependence

> **NCT00689572** · PHASE2 · COMPLETED · sponsor: **University of Virginia** · enrollment: 108 (actual)

## Conditions studied

- Cocaine Dependence

## Interventions

- **DRUG:** Ondansetron
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00689572
- **Lead sponsor:** University of Virginia
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-07
- **Primary completion:** 2013-12
- **Final completion:** 2013-12
- **Target enrollment:** 108 (ACTUAL)
- **Last updated:** 2021-11-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00689572

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00689572, "New Medication Treatment for Stimulant Dependence". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00689572. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*